An algorithm that can classify patients with juvenile idiopathic arthritis (JIA) into seven distinct groups based on patterns of swollen or painful joints in the body can help predict disease course.
Long-term follow-up data show that many adult patients with JIA have active disease with low remission rates.
A series of interventions introduced through a quality improvement project can increase the frequency of both teratogen education and urine pregnancy screening in patients taking teratogenic medications for rheumatic disease.
Gout treatment chart for acute attacks or chronic management/prevention.
NSAIDS (non-steroidal anti-inflammatory drugs) indicated for the treatment of different types of arthritis.
Osteoporosis treatment and prevention doses including recommended calcium and vitamin D supplemental doses.
A comparative list of treatment options for arthritis including DMARDS and other immune modulators.
Includes drugs indicated for different types of arthritis as well as the form and strength the medication is available in.
Patients with juvenile idiopathic arthritis demonstrated evidence of dysbiosis and reduced diversity in the gut microbiome.
Discontinuing TNFi therapy before 20 weeks gestation was feasible in women with RA and JIA who enter pregnancy with well-controlled disease.